MeSH tree: C06.405.205
When harmful bacteria that cause food poisoning, such as E. coli, invade through the digestive tract, gut cells usually fight back by pushing infected cells out of the body to stop the infection from spreading.
Oct 22, 2025
0
84
Researchers at the Icahn School of Medicine at Mount Sinai and their collaborators have developed a new technology to track beneficial bacteria after fecal microbiota transplants (FMT). The approach provides a detailed view ...
Oct 22, 2025
0
54
The "gut microbiome" has become a popular health term in recent years. It's easy to see why, with an abundance of research showing how important the trillions of microbes living in our gut are for health.
Oct 20, 2025
0
0
An opportunistic bacterial infection that causes deadly diarrhea is more likely to kill white patients than Black or Hispanic people, a new study presented at IDWeek says.
Oct 20, 2025
0
0
The rate of Americans diagnosed with digestive disorders and gastrointestinal cancers is rising, especially in those ages 50 and younger, so researchers in the Penn State Department of Nutritional Sciences are studying how ...
Oct 13, 2025
0
0
Reddit's popularity as a tool for self-managing inflammatory bowel disease highlights opportunities for improvements in clinical care, according to a paper published in Journal of Medical Internet Research.
Oct 8, 2025
0
0
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases ...
Oct 3, 2025
0
62
The treatment of a common bowel condition, diverticulitis varies widely across the world. In particular the use of antibiotics is "alarmingly high" according to the biggest data analysis of the disease to date published in ...
Oct 2, 2025
0
0
Immune cells called double negative T cells are abundant in the intestine but have been poorly understood till date. In a recent study, researchers from the Institute of Science Tokyo report that these cells actually have ...
Oct 1, 2025
0
30
The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.
Sep 25, 2025
0
0
